CCO Expert Recap

CCO Expert Recap of data from the 2004 Annual Meeting of the American Association for the Study of Liver Diseases

Source: 2004 Annual Meeting of The American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Hepatitis B Report From the 55th Annual Meeting of the AASLD

Program Director: Patrick J. Lynch, MD

Faculty:

Emmet B. Keeffe, MD, MACP
  • Emmet B. Keeffe, MD, MACP

CME CREDIT INFORMATION

Release Date: 12/02/04

Expiration Date: 12/01/05


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status
Begin the CCO Expert Recap

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the prevention of vertical transmission of HBV.

  • Review approaches for avoiding the development of drug resistance during treatment of chronic hepatitis B, and for treating patients infected with lamivudine-resistant HBV.

  • Describe the results of recent studies of antiviral agents for the treatment of chronic hepatitis B, including adefovir dipivoxil, entecavir, telbivudine, and lamivudine as well as peginterferon and standard interferon.

Slideset

CCO Slideset – Hepatitis B: CCO Independent Conference Coverage of the 2004 Annual Meeting of the AASLD*


Format: Microsoft PowerPoint (.ppt) | File size: 376 KB


Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.